Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2026-01-07 Share Issue/Capital Cha…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - SHG 5 pages 16.2KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (options) for Singular Health Group Ltd. It includes specific information about the securities that have ceased, the reason for cessation (expiry of options), and the updated issued capital following these changes. The document is a formal announcement to the ASX regarding changes in the company's issued capital due to cessation of securities. It does not contain financial statements, management discussion, or other report content. It is a regulatory announcement about capital changes, specifically cessation of securities, which fits best under the category of Share Issue/Capital Change (SHA). The document length is 4732 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is SHA with high confidence.
2026-01-07 English
Appendix 3Y - change of director interest notice 3 pages 7.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number and class of securities before and after the change, nature of the change, and related parties. This type of document is a formal notification of personal share transactions by a company director. It is not a financial report, earnings release, or management announcement but specifically reports insider trades by directors. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is a full notice, not a brief announcement or certification.
2025-12-21 English
Notification of cessation of securities - SHG 5 pages 16.2KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (options) for Singular Health Group Ltd. It includes specific information about the securities that have ceased, the reason for cessation (expiry of options), and the updated issued capital following these changes. The document is a formal announcement to the ASX about changes in the company's issued securities, specifically the cessation of certain options. This type of document is a regulatory announcement related to changes in securities but does not constitute a financial report, earnings release, or management discussion. It is not a report publication announcement since it contains substantive details about the cessation event itself. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-12-21 English
Notification regarding unquoted securities - SHG 9 pages 23.8KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted options as part of remuneration for the Managing Director, approved at the 2025 AGM. It includes specifics about the securities issued, their terms, and references shareholder approval at the AGM. The content is a formal notification of a securities issue rather than a full report or financial statement. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes. The document length (8313 characters) and detailed issuance data confirm it is not a brief announcement or a report publication notice but a substantive notification of capital change.
2025-12-18 English
Release of Securities from Voluntary Escrow 1 page
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the release of restricted securities from voluntary escrow, referencing Listing Rule 3.10A. It does not contain financial statements, detailed financial data, or comprehensive report content. The document is an update on capital structure related to share release but does not indicate a new share issue or capital change event like a stock split or new issuance. It is a regulatory announcement about share escrow release, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories and is a compliance-related disclosure.
2025-12-09 English
Application for quotation of securities - SHG 8 pages 20.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an official announcement from Singular Health Group Ltd regarding the quotation of securities on the ASX. It details the issuance and conversion of options into ordinary fully paid shares, the number of securities to be quoted, issue price, and other related information. This type of document is a formal application for listing new securities following their issuance or conversion, which aligns with announcements about share issues or capital changes. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is sufficient and contains substantive details about the securities issued, not merely a notice or link to a report, so it is not a report publication announcement or regulatory filing fallback.
2025-12-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.